Bleomycin Sulfate & Second primary malignancy

17.4%

of users reported Second primary malignancy

69.5%

also reported Severe reaction

68.4%

are men

Severe reaction

69.5%

Death

26.8%

Hospitalization

2.4%

Life-threatening condition

1.2%

Bleomycin Sulfate: general information

10 - 19 years

17.6%

20 - 29 years

21.6%

30 - 39 years

23.5%

40 - 49 years

9.0%

50 - 59 years

13.3%

60 - 69 years

15.1%